Role of MAP kinase activation in Nramp1 mRNA stability in RAW264.7 macrophages expressing Nramp1Gly169

Cellular Immunology

Volumn 215, Issue 2, 2002, Pages 195-206

  Lafuse, William P ^a   Alvarez, Gail R ^a   Zwilling, Bruce S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Innate resistance; MAP kinases; Mycobacterium avium; Oxidative stress; Protein kinase C

Indexed keywords

ANTIOXIDANT; BUTYLATED HYDROXYANISOLE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; OXIDIZING AGENT; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IRON TRANSPORT; MACROPHAGE; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; RNA STABILITY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIOXIDANTS; BUTYLATED HYDROXYANISOLE; CATION TRANSPORT PROTEINS; CELL LINE; ENZYME ACTIVATION; ENZYME INHIBITORS; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYCOBACTERIUM AVIUM; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; RNA STABILITY; VITAMIN K 3;

MYCOBACTERIUM; MYCOBACTERIUM AVIUM;

EID: 0036387040     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(02)00026-6     Document Type: Article

References (55)

1. E. Skamene, P. Gros, A. Forget, P.A.L. Kongshavin, C. St.-Charles, B.A. Taylor, Genetic regulation of resistance to intracellular pathogens, Nature 297 (1982) 506-510.
2. J.M. Blackwell, T.I.A. Roach, S.E. Atkinson, J.W. Ajioka, C.H. Barton, M.A. Shaw, Genetic regulation of macrophage priming activation: the Lsh/Ity/Bcg gene story continues, Immunol. Lett. 30 (1991) 241-248.
3. S.M. Vidal, D. Malo, K. Vogan, E. Skamene, P. Gros, Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg, Cell 73 (1993) 469-485.
4. S. Vidal, P. Gros, E. Skamene, Natural resistance to infection with intracellular parasites: molecular genetics identified Nramp1 as the Bcg/Ity/Lsh locus, J. Leukoc. Biol. 58 (1995) 382-390.
5. S. Vidal, M.L. Tremblay, G. Govoni, S. Gauthier, G. Sebastini, D. Malo, E. Skamene, M. Olivier, S. Jothy, P. Gros, The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene, J. Exp. Med. 182 (1995) 655-666.
6. G. Govoni, S. Gauthier, F. Billia, N.N. Iscove, P. Gros, Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo, J. Leukoc. Biol. 62 (1997) 277-286.
7. 2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine Src homology 3-binding domain, J. Exp. Med. 179 (1994) 1683-1687.
8. P.G. Atkinson, J.M. Blackwell, C.H. Barton, Nramp1 locus encodes a 65 kDa interferon-γ inducible protein in murine macrophages, Biochem. J. 325 (1997) 779-786.
9. S. Gruenheid, E. Pinner, M. Desjardins, P. Gros, Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome, J. Exp. Med. 185 (1997) 717-730.
10. S. Searle, N.A. Bright, T.I.A. Roach, P.G. Atkinson, C.H. Barton, R.H. Meloen, J.M. Blackwell, Localization of Nramp1 in macrophages: modulation with activation and infection, J. Cell Sci. 111 (1998) 2855-2866.
11. S.M. Vidal, E. Pinner, P. Lepage, S. Gauthier, P. Gros, Natural resistance to intracellular infections, J. Immunol. 157 (1996) 3559-3568.
12. Asp169, J. Leukoc. Biol. 67 (1999) 1386-1392.
13. Gly169 transfected RAW264.7 macrophage cell line, J. Leukoc. Biol. 69 (2001) 43-49.
14. B.S. Zwilling, D.E. Kuhn, L. Wikoff, D. Brown, W.P. Lafuse, Role of iron in Nramp1-mediated inhibition of mycobacterial growth, Infect. Immun. 67 (1999) 1386-1392.
15. N. Jabado, A. Jankoswski, S. Dougaparsad, V. Picard, S. Grinstein, P. Gros, Natural resistance to intracellular infections: natural resistance-associated macrophage protein (NRAMP1) functions as a pH-dependent manganese transporter at the phagosomal membrane, J. Exp. Med. 192 (2000) 1237-1248.
16. +/bivalent cation antiporter, Biochem. J. 354 (2001) 511-519.
17. C.H. Barton, S.H. Whitehead, J.M. Blackwell, Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways, Mol. Med. 1 (1995) 267-279.
18. T.I.A. Roach, D. Chatterjee, J.M. Blackwell, Induction of early response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Ity Lsh/Bcg (candidate Nramp), Infect. Immun. 62 (1994) 1176-1184.
19. r mice occurs via a protein kinase C-dependent pathway, J. Immunol. 152 (1994) 1323-1331.
20. s macrophages is related to differences in protein kinase-C-dependent signaling, Eur. J. Biochem. 251 (1998) 734-743.
21. D. Brown, W.P. Lafuse, B.S. Zwilling, Stabilized expression of mRNA is associated with mycobacterial resistance controlled by Nramp1, Infect. Immun. 65 (1997) 597-603.
22. Gly169, Biochem. J. 351 (2000) 687-696.
23. D.H. Brown, W.P. Lafuse, B.S. Zwilling, Cytokine-mediated activation of macrophages from Mycobacterium bovis BCG-resistant and -susceptible mice: differential effects of corticosterone on antimycobacterial activity and expression of the Bcg gene (Candidate Nramp), Infect. Immun. 63 (1995) 2983-2988.
24. T. Lang, E. Prina, D. Sibthorpe, J.M. Blackwell, Nramp1 transfection transfers Ity Lsh Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation, Infect. Immun. 65 (1997) 380-386.
25. P. Chomczynski, N. Sachi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
26. S.P. Davies, H. Reddy, M. Caivano, P. Cohen, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J. 351 (2000) 95-105.
27. F.V. Lali, A.E. Hunt, S.J. Turner, B.M.J. Foxwell, The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase, J. Biol. Chem. 275 (2000) 7395-7402.
28. T. Finkel, Oxygen radicals and signaling, Curr. Opin. Cell Biol. 10 (1998) 248-253.
29. H. Kappus, Overview of enzyme systems involved in bio-reduction of drugs and in redox cycling, Biochem. Pharmacol. 35 (1986) 1-6.
30. A.B. Shyu, M.E. Greenberg, J.G. Belasco, The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways, Genes Dev. 3 (1989) 60-72.
31. S.S. Peng, C.-Y.A. Chen, N. Xu, A.-B. Shyu, RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein, EMBO J. 17 (1998) 3461-3470.
32. K.M.K. Rao, MAP kinase activation in macrophages, J. Leukoc. Biol. 69 (2001) 3-10.
33. A.B. Carter, M.M. Monick, G.W. Hunninghake, Both Erk and p38 kinases are necessary for cytokine gene transcription, Am. J. Respir. Cell Mol. Biol. 20 (1999) 751-758.
34. D.M. Payne, A.J. Rossomando, P. Martino, A.K. Erickson, J.-H. Her, J. Shananowitz, D.F. Hunt, M.J. Weber, T.W. Sturgill, Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase), EMBO J. 10 (1991) 885-892.
35. R. Seger, N.G. Ahn, J. Posada, E.S. Munar, A.M. Jensen, J.A. Cooper, M.H. Cobb, E.G. Krebs, Purification and characterization of mitogen-activated protein kinase activators from epidermal growth factor-stimulated A431 cells, J. Biol. Chem. 267 (1992) 14373-14381.
36. J.C. Lee, J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, D. Green, D. McNulty, M.J. Blumenthat, J.R. Heys, S.W. Sandvatter, J.E. Strickler, M.M. McLaughlin, I.R. Siemens, S.M. Fisher, G.P. Livi, J.R. White, J.L. Adams, P.R. Young, A protein kinase involved in the regulation of inflammatory cytokine biosynthesis, Nature 372 (1994) 739-746.
37. B. Derijard, J. Raingeaud, T. Barrett, I.-H. Wu, J. Han, R.J. Ulevitch, R.J. Davis, Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms, Science 267 (1995) 682-685.
38. J. Han, J.-D. Lee, Y. Jiang, Z. Li, L. Feng, R.J. Ulevitch, Characterization of the structure and function of a novel MAP kinase kinase (MKK6), J. Biol. Chem. 271 (1996) 2886-2891.
39. M.H. Cobb, E.J. Goldsmith, How MAP kinases are regulated? J. Biol. Chem. 270 (1995) 1483-1486.
40. E. Herlaar, Z. Brown, P38 MAPK signalling cascades in inflammatory disease, Mol. Med. Today 5 (1999) 439-447.
41. G. Martiny-Baron, M.G. Kazanietz, H. Mischak, P.M. Blumberg, G. Kochs, H. Hug, D. Marme, C. Schaechtele, Selective inhibition of protein kinase C isozymes by the indolocarbazole GÖ6976, J. Biol. Chem. 268 (1993) 9194-9197.
42. W. Kolch, G. Heidecker, G. Kochs, R. Himmel, H. Vahidi, H. Mishak, G. Finkenzeller, D. Marne, U.R. Rapp, Protein kinase C alpha activates RAF-1 by direct phosphorylation, Nature 364 (1993) 249-252.
43. A.D. Verin, F. Liu, N. Bogatcheva, T. Borrbiev, M.B. Hershen-son, P. Wang, J.G.N. Garcia, Role of Ras-dependent ERK activation in phorbol ester-induced endothelial cell barrier dysfunction, Am. J. Physiol. Lung Cell Mol. Physiol. 279 (2000) L360-L370.
44. S. Ridley, J.L.E. Dean, S.J. Sarsfield, M. Brook, A.R. Clark, J. Saklatvala, A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA, FEBS Lett. 439 (1998) 75-80.
45. J.L.E. Dean, M. Brook, A.R. Clark, J. Saklatvala, p38 Mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes, J. Biol. Chem. 274 (1999) 264-269.
46. R. Winzen, M. Kracht, B. Ritter, A. Wilhelm, C.-Y.A. Chen, A.-B. Shyu, M. Müller, M. Gaestel, K. Resch, H. Holtmann, The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism, EMBO J. 18 (1999) 4969-4980.
47. C.-Y. Chen, R. Gherzi, J.S. Andersen, G. Gaietta, K. Jürchott, H.-D. Royer, M. Mann, M. Karin, Nucleolin and YB-1 are required for JNK-mediated inteleukin-2 mRNA stabilization during T-cell activation, Genes Dev. 14 (2000) 1236-1248.
48. J.L. Swantek, M.H. Cobb, T.D. Geppert, Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK, Mol. Cell. Biol. 17 (1997) 6274-6282.
49. D. Caput, B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimmer, A. Cerami, Identification of a common nucleotide sequence in the 3′ untranslated regions of mRNA molecules specifying inflammatory mediators, Proc. Natl. Acad. Sci. USA 83 (1986) 1670-1674.
50. J.L. Casey, M.W. Hentze, D.K. Koeller, S.W. Caughman, T.A.R.D. Roualt, J.B. Hartford, Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation, Science 240 (1988) 924-928.
51. A. Toker, Protein kinases as mediators of phosphoinositide 3-kinase signaling, Mol. Pharmacol. 67 (2000) 652-658.
52. T. Finkel, Oxygen radicals and signaling, Curr. Opin. Cell Biol. 10 (1998) 248-253.
53. V. Natarajan, W.M. Scribner, M. Al-Hassani, S. Vepa, Reactive oxygen species signaling through regulation of protein tyrosine phosphorylation in endothelial cells, Environ. Health Perspect. 106 (Suppl. 5) (1998) 1205-1212.
54. 2 and vanadate in vitro, Biochem. Biophys. Res. Commun. 188 (1992) 773-779.
55. R. Gopalakrishna, S. Jaken, Protein kinase C signaling and oxidative stress, Free Radic. Biol. Med. 28 (2000) 1349-1361.